• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受抗逆转录病毒治疗的艾滋病毒感染者对脂肪代谢障碍体征有准确认知:一项横断面研究。

People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.

作者信息

Alencastro Paulo R, Barcellos Nemora T, Wolff Fernando H, Ikeda Maria Letícia R, Schuelter-Trevisol Fabiana, Brandão Ajácio B M, Fuchs Sandra C

机构信息

Hospital Sanatório Partenon, State Department of Health, Rio Grande do Sul. Av. Bento Gonçalves, 3722, Porto Alegre, RS, 90650-001, Brazil.

Post-graduate Program of Collective Health, Universidade do Vale do Rio dos Sinos, Av. Unisinos, 950, São Leopoldo, RS, 93022-750, Brazil.

出版信息

BMC Res Notes. 2017 Jan 13;10(1):40. doi: 10.1186/s13104-017-2377-3.

DOI:10.1186/s13104-017-2377-3
PMID:28086977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234247/
Abstract

BACKGROUND

The prevalence of lipodystrophy ranges from 31 to 65%, depending on the criteria adopted for diagnosis. The usual methods applied in the diagnosis vary from self-perception, medical examination, skinfolds measurements, or even imaging assessment for confirmation of fat distribution changes. Although several methods have been developed, there is no gold standard for characterization of LA and LH, or mixed forms. This study aimed to compare self-reported signs of lipodystrophy with objective measures by skinfolds and circumferences, and to evaluate the prevalence of lipoatrophy (LA) and lipohypertrophy (LH) among subjects living with HIV/AIDS on ART.

METHODS

A cross-sectional study enrolled participants living with HIV/AIDS receiving ART, aged 18 years or older from an outpatient health care center, in Southern Brazil. Self-reported body fat enlargement in the abdomen, chest or breasts, and dorsocervical fat pad were used to determine LH, while LA was identified by self-reported fat wasting of the face, neck, legs, arms or buttocks. Measurements were obtained with a scientific caliper for infraorbital, buccal, and submandibular skinfolds, and using an inelastic tape to measure circumferences of waist, hip, neck, and arm. LH and LA were established by the presence of at least one self-reported sign.

RESULTS

Comparisons of self-reported signs with objective measurements for men and women were carried out in 815 participants on ART, out of 1240 participants with HIV infection. Self-report of decreased facial fat and sunken cheeks was associated with lower infraorbital, buccal, and submandibular skinfolds. Participants who reported buffalo hump had, on average, greater neck circumference, as well as those who have increased waist circumference also reported abdominal enlargement, but no buttock wasting. Men were most commonly affected by lipoatrophy (73 vs. 53%; P < 0.001), and women by lipohypertrophy (79 vs. 56%; P < 0.001).

CONCLUSION

In conclusion, self-reported signs of lipodystrophy and lipoatrophy are prevalent, differ by gender, and are associated with objective measurements in people living with HIV/AIDS.

摘要

背景

脂肪代谢障碍的患病率在31%至65%之间,具体取决于所采用的诊断标准。诊断中常用的方法各不相同,包括自我感知、医学检查、皮褶测量,甚至通过影像学评估来确认脂肪分布变化。尽管已经开发了多种方法,但对于局限性脂肪萎缩(LA)和脂肪增生(LH)或混合形式的特征描述,尚无金标准。本研究旨在比较自我报告的脂肪代谢障碍体征与通过皮褶和周长进行的客观测量,并评估接受抗逆转录病毒治疗(ART)的艾滋病毒/艾滋病患者中脂肪萎缩(LA)和脂肪增生(LH)的患病率。

方法

一项横断面研究纳入了来自巴西南部一家门诊医疗中心的18岁及以上接受ART治疗的艾滋病毒/艾滋病患者。通过自我报告腹部、胸部或乳房的体脂增大以及颈后脂肪垫来确定LH,而通过自我报告面部、颈部、腿部、手臂或臀部的脂肪消耗来确定LA。使用科学卡尺测量眶下、颊部和下颌下皮褶,并使用无弹性卷尺测量腰围、臀围、颈围和臂围。通过至少一种自我报告的体征来确定LH和LA。

结果

在1240名艾滋病毒感染者中,对815名接受ART治疗的参与者进行了自我报告体征与男女客观测量结果的比较。自我报告面部脂肪减少和脸颊凹陷与较低的眶下、颊部和下颌下皮褶相关。报告有水牛背的参与者平均颈围更大,腰围增加的参与者也报告有腹部增大,但没有臀部消瘦。男性最常受脂肪萎缩影响(73%对53%;P<0.001),女性则最常受脂肪增生影响(79%对56%;P<0.001)。

结论

总之,自我报告的脂肪代谢障碍和脂肪萎缩体征普遍存在,存在性别差异,并且与艾滋病毒/艾滋病患者的客观测量结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/88a39b4554f9/13104_2017_2377_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/9057fba8a398/13104_2017_2377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/e98241154b82/13104_2017_2377_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/88a39b4554f9/13104_2017_2377_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/9057fba8a398/13104_2017_2377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/e98241154b82/13104_2017_2377_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e8/5234247/88a39b4554f9/13104_2017_2377_Fig3_HTML.jpg

相似文献

1
People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.接受抗逆转录病毒治疗的艾滋病毒感染者对脂肪代谢障碍体征有准确认知:一项横断面研究。
BMC Res Notes. 2017 Jan 13;10(1):40. doi: 10.1186/s13104-017-2377-3.
2
Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy/lipohypertrophy syndrome.接受抗逆转录病毒治疗且患有脂肪萎缩/脂肪肥大综合征的HIV-1感染患者中体重指数与人体测量结果之间的不一致性。
Rev Inst Med Trop Sao Paulo. 2015 Mar-Apr;57(2):105-10. doi: 10.1590/S0036-46652015000200002.
3
High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染患者中,面部脂肪萎缩及脂肪组织分布的其他异常情况发生率高且对生活质量有影响。
AIDS Res Hum Retroviruses. 2013 May;29(5):761-8. doi: 10.1089/aid.2012.0214. Epub 2013 Feb 25.
4
Self-reported signs of lipodystrophy by persons living with HIV infection.HIV感染者自我报告的脂肪代谢障碍体征。
Int J STD AIDS. 2002 Jun;13(6):393-8. doi: 10.1258/095646202760029813.
5
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.澳大利亚的人类免疫缺陷病毒脂肪代谢障碍:患病率、严重程度及风险相关因素
HIV Med. 2003 Jul;4(3):293-301. doi: 10.1046/j.1468-1293.2003.00159.x.
6
Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.身体变化:抗逆转录病毒疗法与艾滋病毒/艾滋病感染者的脂肪代谢障碍综合征
Rev Lat Am Enfermagem. 2012 Sep-Oct;20(5):847-53. doi: 10.1590/s0104-11692012000500005.
7
The Facial Appearance Inventory: Development and Preliminary Evidence for Reliability and Validity in People with HIV and Lipoatrophy.面部外观量表:HIV感染者和脂肪萎缩患者可靠性和有效性的开发及初步证据
Aesthet Surg J. 2016 Jul;36(7):842-51. doi: 10.1093/asj/sjw010. Epub 2016 Mar 1.
8
Correlation of Leptin, Adiponectin, and Resistin Levels in Different Types of Lipodystrophy in HIV/AIDS Patients.HIV/AIDS患者不同类型脂肪营养不良中瘦素、脂联素和抵抗素水平的相关性
Metab Syndr Relat Disord. 2017 Apr;15(3):153-159. doi: 10.1089/met.2016.0068. Epub 2017 Feb 16.
9
Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging.通过磁共振成像测量的与HIV相关的脂肪萎缩、消瘦和体重增加中面部脂肪的变化。
HIV Clin Trials. 2007 Jul-Aug;8(4):227-34. doi: 10.1310/hct0804-227.
10
Self-reported lipodystrophy, nutritional, lipemic profile and its impact on the body image of HIV-1-infected persons, with and without antiretroviral therapy.自述脂代谢障碍、营养状况、血脂谱及其对接受和未接受抗逆转录病毒治疗的 HIV-1 感染者身体形象的影响。
AIDS Care. 2020 Oct;32(10):1317-1322. doi: 10.1080/09540121.2019.1687832. Epub 2019 Nov 11.

引用本文的文献

1
Forecasting and validating fat mass ratio models through anthropometric measurements and health-related factors among people with HIV: a cross-sectional investigation.通过人体测量和健康相关因素对HIV感染者的脂肪质量比率模型进行预测和验证:一项横断面调查。
Ann Transl Med. 2024 Jun 10;12(3):44. doi: 10.21037/atm-23-1946. Epub 2024 May 29.
2
Comparative analysis of -493G/T and 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients.HIV相关脂肪代谢障碍患者中-493G/T和34G/A多态性及其表达的比较分析。
Front Cardiovasc Med. 2023 May 30;10:1177054. doi: 10.3389/fcvm.2023.1177054. eCollection 2023.
3

本文引用的文献

1
Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria.尼日利亚HIV感染患者脂肪萎缩的患病率及危险因素
AIDS Res Treat. 2015;2015:402638. doi: 10.1155/2015/402638. Epub 2015 Mar 2.
2
HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings.艾滋病毒/艾滋病与脂肪代谢障碍:资源有限环境下对临床管理的影响
J Int AIDS Soc. 2015 Jan 15;18(1):19033. doi: 10.7448/IAS.18.1.19033. eCollection 2015.
3
Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Primary Validation of the Submandibular Skinfold as an Anthropometric Measurement of Cardiometabolic Risk in People with Intellectual Disabilities.
原发性下颌皮肤褶皱作为智力障碍人群心血管代谢风险的人体测量指标的初步验证。
Int J Environ Res Public Health. 2023 Jan 17;20(3):1658. doi: 10.3390/ijerph20031658.
4
Body image in children and adolescents diagnosed with the human immunodeficiency virus: a systematic review.儿童和青少年人类免疫缺陷病毒感染者的身体意象:系统评价。
Sao Paulo Med J. 2022 Nov 21;141(4):e2022154. doi: 10.1590/1516-3180.2022.0154.R2.19082022. eCollection 2022.
5
Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models.脂代谢障碍在 HIV/AIDS 患者中的诊断:基于性别特异性人体测量模型的预测与验证。
BMC Public Health. 2018 Jun 27;18(1):806. doi: 10.1186/s12889-018-5707-z.
6
End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDS.人类免疫缺陷病毒-艾滋病的临终关怀与丧亲问题
Nurs Clin North Am. 2018 Mar;53(1):123-135. doi: 10.1016/j.cnur.2017.10.010.
泰国初治和经治 HIV-1 感染的成年患者代谢综合征的流行率。
AIDS Patient Care STDS. 2014 Jul;28(7):331-40. doi: 10.1089/apc.2013.0294. Epub 2014 Jun 10.
4
HIV-associated lipodystrophy: impact of antiretroviral therapy.HIV 相关脂肪代谢障碍:抗反转录病毒治疗的影响。
Drugs. 2013 Sep;73(13):1431-50. doi: 10.1007/s40265-013-0108-1.
5
Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.抗反转录病毒相关脂肪营养不良的系统评价:脂肪减少,而非中心性脂肪增加,是抗反转录病毒药物不良反应。
PLoS One. 2013 May 28;8(5):e63623. doi: 10.1371/journal.pone.0063623. Print 2013.
6
HIV infection and the risk of acute myocardial infarction.HIV 感染与急性心肌梗死风险。
JAMA Intern Med. 2013 Apr 22;173(8):614-22. doi: 10.1001/jamainternmed.2013.3728.
7
High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染患者中,面部脂肪萎缩及脂肪组织分布的其他异常情况发生率高且对生活质量有影响。
AIDS Res Hum Retroviruses. 2013 May;29(5):761-8. doi: 10.1089/aid.2012.0214. Epub 2013 Feb 25.
8
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.HIV感染中的局部脂肪沉积与心血管风险:FRAM研究
AIDS Care. 2011 Aug;23(8):929-38. doi: 10.1080/09540121.2010.543885. Epub 2011 Jun 24.
9
Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy.脂肪质量比:一种用于定义抗逆转录病毒治疗的 HIV 感染患者脂肪营养不良的客观工具。
J Clin Densitom. 2010 Apr-Jun;13(2):197-203. doi: 10.1016/j.jocd.2010.01.005. Epub 2010 Mar 27.
10
Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions.高效抗逆转录病毒治疗的 HIV 患者身体生理变化的流行情况及其影响:来自一项关于患者和医生认知的研究结果。
AIDS Patient Care STDS. 2010 Jan;24(1):5-13. doi: 10.1089/apc.2009.0191.